Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 28.35% |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -23.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.37% |
| Mar 31, 2026 | -34.72% |
| Dec 31, 2025 | -36.90% |
| Sep 30, 2025 | -36.17% |
| Jun 30, 2025 | -35.31% |
| Mar 31, 2025 | -35.07% |
| Dec 31, 2024 | -30.33% |
| Sep 30, 2024 | -28.75% |
| Jun 30, 2024 | -25.60% |
| Mar 31, 2024 | -18.19% |
| Dec 31, 2023 | -15.92% |
| Sep 30, 2023 | -13.29% |
| Jun 30, 2023 | -11.99% |
| Mar 31, 2023 | 9.28% |
| Dec 31, 2022 | 14.67% |
| Sep 30, 2022 | 15.10% |
| Jun 30, 2022 | 15.33% |
| Mar 31, 2022 | 16.30% |
| Dec 31, 2021 | 16.18% |
| Sep 30, 2021 | 20.89% |